Aclarion Expands Nociscan Network with Indiana’s First Site at Goodman Campbell Brain & Spine
Event summary
- Aclarion’s Nociscan platform is now available at Goodman Campbell Brain & Spine, the first site in Indiana to offer the technology.
- Goodman Campbell is a nationally recognized leader in neurosurgery training and clinical research.
- Nociscan uses Magnetic Resonance Spectroscopy (MRS) to identify painful discs in chronic low back pain patients, with a 97% surgical success rate when all Nociscan-positive discs are treated.
The big picture
Aclarion’s expansion into Indiana with a leading neurosurgery center underscores the growing demand for advanced diagnostic tools in chronic low back pain management. The partnership aligns with broader industry trends toward data-driven, non-invasive solutions that improve treatment outcomes. With approximately 266 million people worldwide suffering from degenerative spine disease, Aclarion’s ability to differentiate Nociscan in a competitive market will be critical.
What we're watching
- Network Expansion Pace
- The pace at which Aclarion can add new provider sites will determine its ability to scale Nociscan’s reach and impact.
- Clinical Adoption
- Whether the technology gains broader acceptance among neurosurgery and spine care networks beyond early adopters.
- Regulatory and Reimbursement Dynamics
- How regulatory approvals and insurance coverage for Nociscan will affect its commercialization strategy.
Related topics